4 free views remaining today
autosomal dominant hypophosphatemic rickets
ICD-10 Codes
Related ICD-10:
Description
Autosomal dominant hypophosphatemic rickets (ADHR) is a rare genetic disorder that affects the body's ability to regulate phosphate levels in the blood. This condition is characterized by:
- Low serum phosphorus concentrations: The level of phosphate in the blood is lower than normal, which can lead to various health problems.
- Phosphaturia: Excessive loss of phosphate in the urine, which further contributes to low phosphate levels in the blood.
- Inappropriately low or normal circulating vitamin D levels: Despite the body's attempts to compensate for low phosphate levels, vitamin D levels remain abnormally low.
ADHR is a hereditary condition, meaning it is passed down from parents to their children. It is caused by mutations in the FGF23 gene, which plays a crucial role in regulating phosphate levels in the body.
The symptoms of ADHR can vary in severity and may include:
- Rickets: A condition that affects bone development in children, leading to softening and weakening of bones.
- Osteomalacia: A condition that affects bone health in adults, causing softening and weakening of bones.
- Bone pain: Pain or tenderness in the bones, which can be a result of rickets or osteomalacia.
- Tooth abscesses: Inflammation of the teeth and surrounding tissues.
Overall, ADHR is a rare and complex condition that requires proper diagnosis and treatment to manage its symptoms and prevent long-term complications.
Additional Characteristics
- Bone pain
- Low serum phosphorus concentrations
- Phosphaturia
- Inappropriately low or normal circulating vitamin D levels
- Rickets
- Osteomalacia
- Tooth abscesses
Signs and Symptoms
Autosomal dominant hypophosphatemic rickets (ADHR) is a rare genetic disorder characterized by low phosphate levels in the blood, leading to various symptoms. The signs and symptoms of ADHR include:
- Bone deformity: One of the most noticeable symptoms of ADHR is bone deformity, which can manifest as bowing of the legs or other bone abnormalities [9].
- Bone pain: Patients with ADHR often experience bone pain, which can be a result of the low phosphate levels affecting bone growth and development [4].
- Increased risk of bone fractures: The weakened bones due to hypophosphatemia increase the risk of bone fractures in individuals with ADHR [9].
- Short stature: Many patients with ADHR have short stature, which is often a result of the impaired bone growth caused by low phosphate levels [3].
- Rickets and osteomalacia: In severe cases, ADHR can lead to rickets or osteomalacia, characterized by softening of the bones due to inadequate mineralization [5].
These symptoms are a result of the genetic mutation affecting the FGF23 gene, leading to impaired phosphate reabsorption in the kidneys and subsequent hypophosphatemia. Early diagnosis and treatment are essential to manage the symptoms and prevent long-term complications.
References: [3] - Context 3 [4] - Context 4 [5] - Context 5 [9] - Context 9
Additional Symptoms
- Bone deformity
- Increased risk of bone fractures
- Rickets and osteomalacia
- bone pain
- short stature
Diagnostic Tests
Autosomal dominant hypophosphatemic rickets (ADHR) can be diagnosed through a combination of clinical evaluation, laboratory investigations, and genetic analysis.
Clinical Evaluation A thorough history and physical examination are essential in diagnosing ADHR. Clinical features may include short stature, bowed legs, and other skeletal deformities [7]. Laboratory investigations should also be conducted to assess serum calcium, phosphate, and alkaline phosphatase levels [8].
Molecular Genetic Testing Genetic testing is a crucial diagnostic tool for ADHR. Sequence analysis of the entire coding region, deletion/duplication analysis, and targeted variant analysis can help confirm the diagnosis [3]. A 13-gene panel that includes assessment of non-coding variants may also be ideal for patients with a clinical suspicion of hypophosphatemic rickets [5].
Differential Diagnosis The differential diagnosis for ADHR includes autosomal recessive hypophosphatemic rickets and other conditions that can present with similar clinical features. Molecular genetic testing can help differentiate between these conditions and confirm the diagnosis of ADHR [9].
References: [3] - Context 3 [5] - Context 5 [7] - Context 7 [8] - Context 8 [9] - Context 9
Additional Diagnostic Tests
- Sequence analysis of the entire coding region
- Targeted variant analysis
- duplication analysis
- 13-gene panel that includes assessment of non-coding variants
Treatment
Autosomal dominant hypophosphatemic rickets (ADHR) is a rare genetic disorder characterized by low phosphate levels in the blood, leading to softening and weakening of bones. The treatment for ADHR focuses on managing symptoms and preventing complications.
Phosphate Supplementation: Oral phosphate replacement is a common treatment approach for ADHR. This involves taking neutral phosphate solution or tablets to help raise phosphate levels in the blood [1].
Vitamin D Therapy: While vitamin D therapy may not be effective in improving bone health in patients with ADHR, it can still be used to manage symptoms such as muscle weakness and fatigue [3].
Burosumab Treatment: Burosumab is a monoclonal antibody that has been shown to be effective in treating ADHR by increasing phosphate levels and improving bone mineralization. It is typically administered intravenously every two weeks [9].
Phosphate and Calcitriol Therapy: In some cases, treatment with phosphate and calcitriol (a form of vitamin D) may also be recommended to help manage symptoms and improve bone health [9].
It's essential to note that the treatment approach for ADHR can vary depending on individual patient needs and circumstances. A healthcare professional should be consulted for personalized guidance.
References: [1] - Treatment of hypophosphatemic rickets consists of neutral phosphate solution or tablets. [3] - Treatment with vitamin D produced no change in the rachitic state of these patients, even at rather high doses, leading to the term vitamin D–resistant rickets. [9] - Outline · - Treatment with burosumab · Children · Adults · - Treatment with phosphate and calcitriol · Children · Adults
Recommended Medications
- Vitamin D Therapy
- Burosumab Treatment
- Phosphate and Calcitriol Therapy
- phosphate
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Based on the provided context, it appears that differential diagnosis refers to the process of distinguishing between different possible causes or conditions that may present with similar symptoms.
Autosomal dominant hypophosphatemic rickets (ADHR) is a rare genetic disorder characterized by low phosphate levels in the blood and impaired mineralization of bones. To determine the differential diagnosis for ADHR, we need to consider other conditions that may share similar clinical features.
Possible Differential Diagnoses:
- X-linked hypophosphatemia: This condition is caused by mutations in the PHEX gene and presents with similar symptoms to ADHR, including low phosphate levels and impaired bone mineralization.
- Vitamin D-resistant rickets: This condition is characterized by impaired bone mineralization despite normal or elevated vitamin D levels. It may present with similar symptoms to ADHR, including low phosphate levels and skeletal abnormalities.
- Fibrous dysplasia: This rare genetic disorder affects the bones and can cause a range of symptoms, including skeletal deformities and abnormal bone mineralization.
Key Features to Consider:
- Genetic testing: Genetic testing for mutations in the PHEX gene or other relevant genes may be necessary to confirm the diagnosis of ADHR.
- Clinical presentation: The clinical presentation of ADHR, including symptoms such as rickets, osteomalacia, and skeletal deformities, should be carefully evaluated to rule out other conditions.
- Laboratory findings: Laboratory findings, including phosphate levels, vitamin D levels, and bone mineral density, may also provide clues for differential diagnosis.
References:
- [12] Differential has multiple meanings in mathematics, science, technology, social sciences, medicine and other fields. Learn about the different types and uses of differential, such as in calculus, geometry, mechanics, cryptography, diagnosis and more.
- [13] differential, in mathematics, an expression based on the derivative of a function, useful for approximating certain values of the function. The derivative of a function at the point x 0, written as f′(x 0), is defined as the limit as Δx approaches 0 of the quotient Δy/Δx, in which Δy is f(x 0 + Δx) − f(x 0). Because the derivative is defined as the limit, the closer Δx is to 0, the ...
- [14] Learn the definition, history and usage of the differential of a function in calculus. The differential is the principal part of the change in a function with respect to changes in the independent variable, and can be defined in various ways depending on the context and level of rigor.
Note: The above response is based solely on the provided context and may not reflect the most up-to-date or comprehensive information on the topic.
Additional Differential Diagnoses
- Vitamin D-resistant rickets
- X-linked hypophosphatemia
- fibrous dysplasia
- autosomal recessive hypophosphatemic rickets
- X-linked dominant disease
- hypophosphatemic nephrolithiasis/osteoporosis 2
- hypophosphatemic nephrolithiasis/osteoporosis
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#created_by
- lschriml
- oboInOwl#creation_date
- 2015-10-01T12:10:30Z
- oboInOwl#id
- DOID:0050948
- core#notation
- DOID:0050948
- oboInOwl#hasDbXref
- MIM:193100
- IAO_0000115
- A rickets characterized by low levels of serum phosphate and elevated levels of ALP and phosphaturia and that has_material_basis_in autosomal dominant inheritance.
- rdf-schema#label
- autosomal dominant hypophosphatemic rickets
- rdf-schema#subClassOf
- t336689
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- relatedICD
- http://example.org/icd10/M89.541
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_982
- owl#annotatedSource
- t336169
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.